-
Many patients who receive pacemakers or implantable cardioverter defibrillators (ICDs) are chronically treated with antiplatelet agents, warfarin, or a combination of the two. In this paper, Tompkins and colleagues from the Johns Hopkins Hospital report the results of a retrospective review of antiplatelet and anticoagulant management in patients receiving cardiac-rhythm devices.
-
The evolution of percutaneous coronary intervention (PCI) techniques has resulted in PCI becoming a reasonable alternative to coronary artery bypass graft (CABG) surgery in selected patients with unprotected left-main coronary artery (ULMCA) stenosis.
-
The Medtronic Sprint-Fidelis ICD-lead family is associated with an increased risk for lead fracture.
-
Postural orthostatic tachycardia syndrome (POTS) is a disabling orthostatic intolerance that mainly occurs in pre-menopausal women.
-
Aggressive approach to CVD reduces MI, folic acid and vitamin B12 for CAD, corticosteroids for acute exacerbations of COPD, prescription drug abuse among young adults, and ARBs and cancer risk.
-
Ischemic cardiomyopathy remains a frequent cause of heart failure. Management of patients with coronary artery disease with LV dysfunction has traditionally been achieved with coronary artery bypass graft surgery (CABG). More recently, percutaneous coronary intervention (PCI) has shown similar results to CABG in patients with multi-vessel coronary artery disease.
-
In this study, Sacher and colleagues, from three well-know ablation centers, report their experience with epicardial ventricular tachycardia (VT) ablation.
-
Ambulatory cardiac telemetry uses a cellular phone monitor to continuously receive transmissions from a sensor on the patient, interpret them, and send ECG strips, considered to be possibly dangerous arrhythmias, to a central station for review and possible intervention.
-
-
New reports about proton pump inhibitors and the effects of gastric suppression, pioglitazone vs vitamin E for non-alcoholic steatohepatitis, metformin and vitamin B12 deficiency, and FDA Actions
